Furthermore, ER stress and inflammation regulate and promote each other during obesity66 and A-FABP is involved in both of them, inhibition of A-FABP and induction of autophagic flux may be the potential therapeutic strategies for the treatment of obesity-related inflammatory complications. Here, FABP4 is linked to Obesity.